Chamomile Extract 100 mg × 4 Daily for 12 Weeks Eases Multiple Menopause Symptoms — Menopause Journal 2025 RCT
WELLNESS

Chamomile Extract 100 mg × 4 Daily for 12 Weeks Eases Multiple Menopause Symptoms — Menopause Journal 2025 RCT

By Polly · · Menopause Journal
KO | EN

A 12-week triple-blind RCT in Menopause (January 2025) of 80 postmenopausal women aged 47-62 found that standardized chamomile extract (1.2% apigenin) at 100 mg four times daily simultaneously improved hot flashes, night sweats, mood swings, joint and muscle discomfort, and urinary symptoms vs placebo. Meaningful evidence for non-pharmacologic menopause symptom management beyond hormone replacement therapy.

The Data

  • n: 80 postmenopausal women, ages 47-62
  • Duration: 12 weeks
  • Design: triple-blind randomized placebo-controlled
  • Drug: chamomile standardized extract 100 mg (apigenin 1.2% standardized) 4x daily = 400 mg total daily
  • Improved areas (vs placebo, statistically significant):
    • Hot flash frequency and intensity
    • Night sweats
    • Mood fluctuations (depression, irritability)
    • Joint and muscle discomfort
    • Urinary symptoms (frequency, nocturia)
  • Side effects: minimal, placebo-level
  • Long-term safety: 12-week RCT only; 6-month and 1-year data needed

A single botanical improving five symptom domains simultaneously is uncommon in menopause management.

How Chamomile Works Across Multiple Systems

Chamomile’s key actives are apigenin, α-bisabolol, and chamazulene. Apigenin acts most broadly.

Nervous System

  • GABA-A receptor binding: partial benzodiazepine site affinity → calming + sleep
  • Serotonin modulation: depression + mood stability
  • NMDA blockade: chronic pain reduction

Vascular

  • NO signaling modulation: hot flash reduction (lower vasodilation frequency)
  • Inflammatory cytokine reduction: chronic inflammation easing

Hormonal

  • Weak estrogen mimicry: mild phytoestrogen effect
  • CYP1A2 influence: estrogen metabolism support

Immune

  • NF-κB blockade: inflammation reduction
  • Mast cell stabilization: allergy + itch reduction

Five-system action explains the breadth of menopause symptom relief.

”Herbs = Weak” Perception vs Data

Traditional herb perception: weak, supplemental. Chamomile clinical reality: 400 mg daily (apigenin 4.8 mg) for 12 weeks → clear multi-domain effect.

Comparison:

  • HRT: powerful but cardiovascular and breast cancer risks + prescription required
  • SSRIs: partial hot flash relief, depression + side effect tradeoff
  • Black cohosh: dominant on hot flashes, less effect on mood/urinary
  • Standardized chamomile: 5-domain simultaneous + safe + OTC-feasible

Standardization is decisive. Regular chamomile tea has variable apigenin content. Standardized extract enables reproducible clinical effects.

Korean Menopause Market

Korean menopausal women: ~12 million (50+). HRT use rate: 5-10%, lower than US/Europe due to:

  • Concerns from 2002 WHI study (cardiovascular, breast cancer)
  • Regular consultation burden
  • Preference for non-pharmacologic options

Non-pharmacologic options:

  • Black cohosh
  • Daidzein (soy isoflavones)
  • Maca
  • Vitamin D + calcium
  • DHEA

Standardized chamomile + 1.2% apigenin supplements rare in Korea. Plain chamomile tea provides only mild calming. Future opportunity for standardized formulations.

Chamomile Tea vs Standardized Extract

Chamomile Tea

  • 1 cup = 1-2 g flowers, ~0.5-2 mg apigenin
  • Reaching clinical dose (apigenin 4.8 mg/day) = 5-10 cups daily
  • Impractical + caffeine-free comfort use only

Standardized Extract Supplement

  • Capsule 100 mg with apigenin 1.2 mg
  • 4x daily = apigenin 4.8 mg
  • Reproducible clinical effect
  • Korea = import options (Vital Nutrients, Pure Encapsulations)

Clinical Application

  • Indication: postmenopausal women with hot flashes + mood + sleep + joint discomfort
  • Dose: standardized extract 100 mg (apigenin 1.2%) 4x daily = 400 mg total
  • Time to effect: 4 weeks first change, 12 weeks stable
  • Side effects: rare; chamomile (Asteraceae) allergy contraindicated
  • Contraindications: warfarin (chamomile mild anticoagulant), pregnancy
  • Interactions: SSRI, benzodiazepines, cyclosporine
  • Synergy stack: chamomile + vitamin D + magnesium glycinate + exercise + sleep hygiene
  • HRT alternative: viable first-line for HRT contraindicated/declined patients
  • Long-term gap: 12-week RCT only — 6 month and 1 year data pending